ArticleMuscle & nerve2026
Psychosocial Determinants of Pain in Muscle Biopsy.
Article in Muscle & nerve, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
aimsOpen muscle biopsy (OMB) is a key diagnostic tool for neuromuscular diseases, though patients often worry about risks and discomfort. This study aimed to assess pain during and after OMB, factors influencing pain perception, and adverse events.
methodsIn this single-center prospective study at the Neuropathology Unit of the Pitié-Salpêtrière Hospital, Paris, 100 patients (68 women; mean age 55.4 years) aged ≥ 18 years with suspected myopathy were enrolled from August 2024 to June 2025. Exclusion criteria were inability to understand French, pregnancy, and no social security coverage. Patients completed the numerical rating scale (NRS) for pain assessment and the Patient Health Questionnaire-9. Descriptive statistics summarized patient characteristics. Univariate and multivariate linear regression analyses identified factors associated with procedural pain. Follow-up phone calls were performed at 15 and 30 days postbiopsy.
resultsProcedural pain was mild (median NRS = 2) with moderate and weak positive correlations with preprocedural anxiety (r = 0.54, p < 0.01) and Clinical Frailty Scale scores (r = 0.32, p = 0.02), respectively. Weak negative correlations were observed with satisfaction with staff communication (r = -0.29, p = 0.02) and comfort with medical staff (r = -0.27, p = 0.05). Postprocedural discomfort occurred in 42/83 patients, mostly short-lived. No major complications occurred. DISCUSSION: OMB is a safe procedure. Pain intensity was lower than that generally reported in the literature. Frailty may influence acute pain perception. Preprocedural anxiety emerged as the strongest predictor of pain intensity. Therefore, preprocedural anxiety should be routinely addressed in patients undergoing OMB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.